Jason Greenberg retweeted
Researchers have identified a biomarker panel that improves the assessment of chronic kidney disease (CKD) progression in children.
Learn more about the research.
@YaleNephrology @YalePediatrics @JasonHenryG @fperrywilson
medicine.yale.edu/internal-m…
Jason Greenberg retweeted
In this study, three distinct kidney health dimensions were identified, and each associated with CKD progression and/or all-cause mortality in persons with diabetes and CKD. bit.ly/CJASN0676
#ASNCJASN
Jason Greenberg retweeted
In this study, the authors used bootstrapped survival trees to identify a combination of biomarkers to predict CKD progression in children. bit.ly/JASN0602
@EpiAli
@fperrywilson
@funsocdoc
@JasonHenryG
@kidneydrchirag
@ogutierrez136
@shlipak_khrc
@waikarss
@Yunwen2020
Jason Greenberg retweeted
Thrilled and very proud of @Nephronette who will be presenting the results of the Kidney Action Team Trial at #kidneywk in San Diego this month.
Did personalized, real-time recommendations for initial diagnosis and management of AKI (N=4,003) move the needle on AKI outcomes? Join us and find out!
Jason Greenberg retweeted
Excited to share that our study on long-term outcomes after pediatric AKI (not treated with dialysis) was just published in @JASN_News.
Childhood AKI survivors were at >2x higher risk of long-term CKD, kidney failure, hypertension, and subsequent AKI.
journals.lww.com/jasn/abstra…
Jason Greenberg retweeted
Woohoo!!! At long last, the #SUPERHERO_Registry is LIVE and published!
Check out our website: school.wakehealth.edu/superh…
And our Methods paper:
academic.oup.com/aje/advance…
Thanks @AmJEpi @wakeforestmed @WFCTSI @WFBMI @WakePeds and all our sites and teammates!
Jason Greenberg retweeted
Excited to share our new paper on the long-term outcomes of #COVID-associated #AKI in @JAMAInternalMed. Just out now!🧵
Jason Greenberg retweeted
edhub.ama-assn.org/jn-learni… Excellent podcast on secondary hypertension in children
edhub.ama-assn.org/jn-learni… Excellent podcast on secondary hypertension in children
Jason Greenberg retweeted
Fundraiser by Oren Kanner : Support the Neeman family in memory of Eitan gofund.me/3b8acc16
Support the Neeman family in memory of Eitan
gofund.me/7206d43f
Jason Greenberg retweeted
Left ventricular hypertrophy (LVH) is linked to increased risk of cardiovascular disease & mortality. This study shows higher plasma & urine KIM-1, urine MCP-1, & lower urine alpha-1m were linked to LVH prevalence in children with CKD bit.ly/KID0183
@SarahJSchrauben
Jason Greenberg retweeted
AKI in children is assoc w/increased morbidity, reduced quality of life, greater resource utilization, & higher mortality. Read these Conf Proceedings on existing, novel, & pending diagnostic & risk-stratification tools for pediatric AKI. #OpenAccess
link.springer.com/article/10…
Jason Greenberg retweeted
Do not miss the @padqi compendium articles in @Ped_Neph
#PedsICU #OpenAccess
A proposed framework for advancing acute kidney injury risk stratification and diagnosis in children
@DanaFuhrman4 @AkcanArikan @slgold777
link.springer.com/article/10…
Jason Greenberg retweeted
A brief thread on our recently published work on CXCL9 as a diagnostic biomarker for acute tubulointerstitial nephritis (AIN) jci.org/articles/view/168950 @jclinicalinvest @YaleMed @YaleIMed @YaleNephrology @KidneydrChirag @fperrywilson
Jason Greenberg retweeted
Enjoy reading our review: Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease karger.com/nef/article/doi/1… @JasonHenryG @nephron_journal #MedTwitter @YalePediatrics #IPNAJC #NephJC
Jason Greenberg retweeted
#Hypertension , Blood Pressure Variability, and Acute Kidney Injury in Hospitalized Children ow.ly/oMBE30svcvT @JAHA_AHA #BP #AKI @JasonHenryG & colleagues
Jason Greenberg retweeted
Long-term Health Care Utilization & Costs After Dialysis-Treated AKI in Children
buff.ly/44VFPZT (FREE)
@KidneyCal @JenniferKlowak @NivethikaJ @DrRonWald @AmitXGarg @dani_marie28 @JasonHenryG @DDD_Askenazi @slgold777 @drsamsilver @DrRulanParekh @ChanchlaniRahul
Jason Greenberg retweeted
Results of our ELAIA-2 trial, randomizing patients with Acute Kidney Injury and key drug exposures to alert vs. no-alert now online and free to view @NatureComms!
rdcu.be/dclK2
(Thread)



























